alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Dyskinesia, Medication-Induced in 2 studies
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tamano, H | 1 |
| Morioka, H | 1 |
| Nishio, R | 1 |
| Takeuchi, A | 1 |
| Takeda, A | 1 |
| Calon, F | 1 |
| Rajput, AH | 1 |
| Hornykiewicz, O | 1 |
| Bédard, PJ | 1 |
| Di Paolo, T | 1 |
2 other studies available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
AMPA-induced extracellular Zn
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Chelating Agents; Dopaminergic Ne | 2018 |
Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.
Topics: Aged; Aged, 80 and over; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Binding Sites; Bi | 2003 |